anticoags: HEPARIN
by Anneke Klomp
1. low molecular weight
1.1. dalteparin; enoxaparin; tinzaparin
1.2. prophylaxis AND tx for DVT and PE
1.3. enoxaparin tx ACS
1.4. predictable dose
1.4.1. no lab monitoring
1.5. longer 1/2 life
1.6. outpt tx: LMWH overlapped w/warfarin for 5 days
1.7. AE: bleeding; less thrombocytopenia than unfractionated
2. heparin derivative: heparinoid
2.1. Fondaparinux
2.2. MOA: heparin derivative; binds to antithrombin which inhibits factor Xa; indirectly inhibit conversion of prothrombin to thrombin
2.3. approved for HIT, DVT prevention, ACS; subq administration
3. Protamine sulfate; a reversal for heparin od
4. MOA: accelerates ability of antithrombin to active coag->
4.1. prevents thrombus prop by facilitating fibrinolysis BUT does not lyse existing thrombi
5. unfractionated
5.1. short half life (rapid anticoag)
5.2. tx of DVT/PE; prophylaxis for VTE; acute coronary syndrome
5.3. safe in pregnancy
5.4. variable dosing ->
5.4.1. adjust dosage according to aPTT